All Eyes On DOJ As Novartis FCA Deal Takes Shape

By Jeff Overley (October 27, 2015, 10:59 PM EDT) -- Novartis AG's tentative settlement Tuesday of kickback allegations for $390 million marked yet another huge False Claims Act payout that wasn't accompanied by punishment for individuals, and any final deal could indicate how aggressively the U.S. Department of Justice will enforce its threats to prosecute Big Pharma management for fraud....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!